1995
DOI: 10.1111/j.1365-2141.1995.tb05202.x
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a – b–) phenotype

Abstract: The erythrocyte chemokine receptor, a receptor for Plasmodium vivax, carries the antigens of the Duffy blood group system. Sequence analysis of reticulocyte RNA from individuals of known Duffy phenotype showed that the Fya antigen differs from the Fyb antigen as a result of a single nucleotide difference (A131 or G) encoding amino acid Gly44 (Fya) or Asp (Fyb) in the N-terminal extracellular domain of the glycoprotein. Evidence is presented for two different genetic backgrounds giving rise to the Fy(a-b-) phen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
102
2
3

Year Published

1997
1997
2013
2013

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 146 publications
(108 citation statements)
references
References 33 publications
1
102
2
3
Order By: Relevance
“…That individuals in areas prone to Plasmodium vivax malaria have developed erythroid-specific promoter mutations that abolish expression of DARC on red blood cells, yet retain expression of DARC in other tissues argues for an important physiological role for DARC (Tournamille et al, 1995;Zimmerman et al, 1999). However, this evidence needs to be married with data from both DARC knockout mice and individuals who fail to express DARC as a result of rare coding region mutations, yet have an apparently normal phenotype (Mallinson et al, 1995;Luo et al, 2000).…”
Section: Discussionmentioning
confidence: 71%
“…That individuals in areas prone to Plasmodium vivax malaria have developed erythroid-specific promoter mutations that abolish expression of DARC on red blood cells, yet retain expression of DARC in other tissues argues for an important physiological role for DARC (Tournamille et al, 1995;Zimmerman et al, 1999). However, this evidence needs to be married with data from both DARC knockout mice and individuals who fail to express DARC as a result of rare coding region mutations, yet have an apparently normal phenotype (Mallinson et al, 1995;Luo et al, 2000).…”
Section: Discussionmentioning
confidence: 71%
“…This possible association could, for example, be detected by carrying out a study of the Fy genotype and its mutations. 25 …”
Section: Discussionmentioning
confidence: 99%
“…1B shows that, in a dose-dependent fashion, IL-8 could displace the three bound anti-Fy mAbs and that a plateau corresponding to 30% and 40% displacement was reached when 200 nM IL-8 was added after incubation with anti-Fy6 and anti-Fy a or anti-Fy3, respectively. polymorphism, associated with a G42D substitution (9, 13, 26, 29) has no effect on the chemokine receptor properties of DARC (20,29). In the converse experiment, red cells were preincubated with various amounts of unlabeled IL-8 before anti-Fy mAbs were added.…”
Section: Cross-displacement Binding Of Il-8 and Anti-fy Mabs Tomentioning
confidence: 99%